Drugs / Tegafur/uracil
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00890188 | Jan 2009 → Dec 2010 | colorectal cancer | National Cheng-Kung University Hospital | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Tegafur/uracil | “Tegafur/uracil (UFUR) is one of the effective chemotherapeutics reported to be an effective antiangiogenic agent in an animal model of metastatic colorectal cancers (CRCs).” NCT00890188 ↗ |
| Known as | UFUR | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00890188 ↗ |